PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21277363-4	2011	Fluvoxamine maleate, gemfibrozil, amiodarone hydrochloride, omeprazole, quinidine, diethyldithiocarbamic acid and ketoconazole were successfully applied as test inhibitors for CYP1A2, CYP2C8, CYP2C9, CYP2C19*1, CYP2D6*1, CYP2E1 and CYP3A4/5 in HLMs, respectively.	Ditiocarb	83-109	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	176-182	
20081260-0	2009	Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes.	Ditiocarb	10-32	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	58-64	
20081260-0	2009	Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes.	Ditiocarb	34-37	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	58-64	
20081260-4	2009	A comparative in vitro study provides clear evidence that ticlopidine and DDC, applied at concentrations that inhibit the above-mentioned CYP isoforms, potently (as compared to furafylline) inhibit human CYP1A2 and caffeine metabolism, in particular 1-N- and 3-N-demethylation.	Ditiocarb	74-77	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	204-210	
18950609-12	2009	Results with the isoform-selective inhibitors suggest that the isoforms inhibited by ketoconazole (mainly CYP3A4) and diethyldithiocarbamate (mainly CYP2A6, and CYP2E1), but not the isoforms inhibited by furafylline (mainly CYP1A2), sulfaphenazole (mainly CYP2C9) and quinidine (mainly CYP2D6) are involved in the metabolic activation of AFB1.	Ditiocarb	118-140	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	224-230	
9394024-11	1997	Diethyldithiocarbamate inhibited pentoxifylline formation by 85.7% in cDNA expressed CYP1A2.	Ditiocarb	0-22	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	85-91	
27414036-0	2016	The comparative effects of diethyldithiocarbamate-copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytes.	Ditiocarb	27-49	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	128-134	
27414036-5	2016	Diethyldithiocarbamate-copper complex revealed inconsistent and rather modulatory effect on the expression of CYP1A2 and CYP3A4 in several cultures of human hepatocytes.	Ditiocarb	0-22	cytochrome P450 family 1 subfamily A member 2	Homo sapiens	110-116